J. Arnold Wealth Management’s iShares Biotechnology ETF IBB Stock Holding History

J. Arnold Wealth Management’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-370	Closed	-$48.6K	–	68
2022 Q4	$48.6K	Buy	+370	New	+$47.8K	0.02%	55
2021 Q3	–	Sell	-270	Closed	-$44K	–	78
2021 Q2	$44K	Buy	+270	New	+$41.6K	0.02%	63
2021 Q1	–	Sell	-300	Closed	-$45K	–	104
2020 Q4	$45K	Sell	300 -15	-5%	-$2.14K	0.03%	54
2020 Q3	$43K	Sell	315 -85	-21%	-$11.5K	0.03%	42
2020 Q2	$55K	Buy	+400	New	+$51K	0.05%	49

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

J. Arnold Wealth Management's IBB Position: Q1 2023 in Review

J. Arnold Wealth Management sold out of iShares Biotechnology ETF (IBB) in Q1 2023, closing a stake of 370 shares — an estimated $48.6K sold.

J. Arnold Wealth Management first reported a position in IBB in Q2 2020 and held it in 5 quarters. The position peaked at $55K in Q2 2020. 866 funds tracked by Wall St. Rank hold IBB as of Q1 2023.

J. Arnold Wealth Management reported no remaining iShares Biotechnology ETF position as of Q1 2023 after selling out during the quarter.
J. Arnold Wealth Management sold 370 iShares Biotechnology ETF shares in Q1 2023, an estimated $48.6K.
J. Arnold Wealth Management first reported a position in iShares Biotechnology ETF in Q2 2020 and held it in 5 quarters.
J. Arnold Wealth Management's iShares Biotechnology ETF position peaked at $55K in Q2 2020.
866 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2023.

Based on J. Arnold Wealth Management's 13F filing for Q1 2023, filed 19 Apr 2023.